Our in vivo and in vitro results demonstrated that activated primary PSC from pancreatic cancer tissues typically expressed high levels of SDF-1α, while high CXCR4 expression was typically observed in PCCs. This evidence concerns the gene CXCR4 and pancreatic neoplasm.